nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A2—Cladribine—multiple sclerosis	0.223	0.348	CbGbCtD
Phenoxybenzamine—SLC22A1—Cladribine—multiple sclerosis	0.193	0.302	CbGbCtD
Phenoxybenzamine—CYP3A4—Fingolimod—multiple sclerosis	0.0551	0.086	CbGbCtD
Phenoxybenzamine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0355	0.0554	CbGbCtD
Phenoxybenzamine—CYP3A4—Triamcinolone—multiple sclerosis	0.0269	0.042	CbGbCtD
Phenoxybenzamine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0259	0.0404	CbGbCtD
Phenoxybenzamine—CYP3A4—Betamethasone—multiple sclerosis	0.0231	0.0361	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisolone—multiple sclerosis	0.0228	0.0356	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisone—multiple sclerosis	0.0215	0.0336	CbGbCtD
Phenoxybenzamine—CYP3A4—Dexamethasone—multiple sclerosis	0.0134	0.021	CbGbCtD
Phenoxybenzamine—CALM1—trigeminal nerve—multiple sclerosis	0.0117	0.0924	CbGeAlD
Phenoxybenzamine—CALM2—pons—multiple sclerosis	0.00829	0.0654	CbGeAlD
Phenoxybenzamine—CALM1—pons—multiple sclerosis	0.00826	0.0651	CbGeAlD
Phenoxybenzamine—CALM2—pineal body—multiple sclerosis	0.00592	0.0467	CbGeAlD
Phenoxybenzamine—CALM1—pineal body—multiple sclerosis	0.00589	0.0465	CbGeAlD
Phenoxybenzamine—CALM2—peripheral nervous system—multiple sclerosis	0.00552	0.0435	CbGeAlD
Phenoxybenzamine—CALM1—peripheral nervous system—multiple sclerosis	0.00549	0.0433	CbGeAlD
Phenoxybenzamine—CALM2—nerve—multiple sclerosis	0.0043	0.0339	CbGeAlD
Phenoxybenzamine—CALM1—nerve—multiple sclerosis	0.00428	0.0338	CbGeAlD
Phenoxybenzamine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00394	0.031	CbGeAlD
Phenoxybenzamine—CALM3—retina—multiple sclerosis	0.00227	0.0179	CbGeAlD
Phenoxybenzamine—CALM2—brainstem—multiple sclerosis	0.00185	0.0146	CbGeAlD
Phenoxybenzamine—CALM1—brainstem—multiple sclerosis	0.00184	0.0145	CbGeAlD
Phenoxybenzamine—CALM2—retina—multiple sclerosis	0.00178	0.014	CbGeAlD
Phenoxybenzamine—CALM1—retina—multiple sclerosis	0.00177	0.014	CbGeAlD
Phenoxybenzamine—ADRA1A—brainstem—multiple sclerosis	0.00173	0.0137	CbGeAlD
Phenoxybenzamine—CALM3—medulla oblongata—multiple sclerosis	0.00164	0.0129	CbGeAlD
Phenoxybenzamine—ADRA1B—nervous system—multiple sclerosis	0.00162	0.0127	CbGeAlD
Phenoxybenzamine—ADRA1D—nervous system—multiple sclerosis	0.00158	0.0125	CbGeAlD
Phenoxybenzamine—ADRA1B—central nervous system—multiple sclerosis	0.00156	0.0123	CbGeAlD
Phenoxybenzamine—ADRA1D—central nervous system—multiple sclerosis	0.00152	0.012	CbGeAlD
Phenoxybenzamine—CALM3—midbrain—multiple sclerosis	0.0015	0.0118	CbGeAlD
Phenoxybenzamine—CALM3—spinal cord—multiple sclerosis	0.00146	0.0115	CbGeAlD
Phenoxybenzamine—CALM2—medulla oblongata—multiple sclerosis	0.00129	0.0102	CbGeAlD
Phenoxybenzamine—CALM1—medulla oblongata—multiple sclerosis	0.00128	0.0101	CbGeAlD
Phenoxybenzamine—ADRA1B—brain—multiple sclerosis	0.00123	0.00973	CbGeAlD
Phenoxybenzamine—ADRA1D—brain—multiple sclerosis	0.00121	0.00952	CbGeAlD
Phenoxybenzamine—SLC22A1—nervous system—multiple sclerosis	0.00119	0.0094	CbGeAlD
Phenoxybenzamine—CALM2—midbrain—multiple sclerosis	0.00118	0.00928	CbGeAlD
Phenoxybenzamine—CALM1—midbrain—multiple sclerosis	0.00117	0.00924	CbGeAlD
Phenoxybenzamine—CALM3—cerebellum—multiple sclerosis	0.00116	0.00914	CbGeAlD
Phenoxybenzamine—ADRA2C—medulla oblongata—multiple sclerosis	0.00115	0.00907	CbGeAlD
Phenoxybenzamine—CALM2—spinal cord—multiple sclerosis	0.00115	0.00905	CbGeAlD
Phenoxybenzamine—SLC22A1—central nervous system—multiple sclerosis	0.00115	0.00905	CbGeAlD
Phenoxybenzamine—CALM1—spinal cord—multiple sclerosis	0.00114	0.00901	CbGeAlD
Phenoxybenzamine—SLC22A3—nervous system—multiple sclerosis	0.00114	0.00898	CbGeAlD
Phenoxybenzamine—SLC22A3—central nervous system—multiple sclerosis	0.0011	0.00865	CbGeAlD
Phenoxybenzamine—ADRA2C—midbrain—multiple sclerosis	0.00105	0.00829	CbGeAlD
Phenoxybenzamine—ADRA2C—spinal cord—multiple sclerosis	0.00103	0.00809	CbGeAlD
Phenoxybenzamine—CALM2—nervous system—multiple sclerosis	0.000968	0.00763	CbGeAlD
Phenoxybenzamine—CALM1—nervous system—multiple sclerosis	0.000963	0.00759	CbGeAlD
Phenoxybenzamine—CALM3—brain—multiple sclerosis	0.000942	0.00742	CbGeAlD
Phenoxybenzamine—CALM2—central nervous system—multiple sclerosis	0.000932	0.00734	CbGeAlD
Phenoxybenzamine—CALM1—central nervous system—multiple sclerosis	0.000927	0.00731	CbGeAlD
Phenoxybenzamine—ADRA2A—medulla oblongata—multiple sclerosis	0.000918	0.00724	CbGeAlD
Phenoxybenzamine—SLC22A1—brain—multiple sclerosis	0.000911	0.00718	CbGeAlD
Phenoxybenzamine—CALM2—cerebellum—multiple sclerosis	0.00091	0.00718	CbGeAlD
Phenoxybenzamine—ADRA1A—nervous system—multiple sclerosis	0.000907	0.00715	CbGeAlD
Phenoxybenzamine—CALM1—cerebellum—multiple sclerosis	0.000906	0.00715	CbGeAlD
Phenoxybenzamine—ADRA1A—central nervous system—multiple sclerosis	0.000874	0.00689	CbGeAlD
Phenoxybenzamine—SLC22A3—brain—multiple sclerosis	0.000871	0.00686	CbGeAlD
Phenoxybenzamine—ADRA2C—nervous system—multiple sclerosis	0.000865	0.00682	CbGeAlD
Phenoxybenzamine—ADRA1A—cerebellum—multiple sclerosis	0.000854	0.00673	CbGeAlD
Phenoxybenzamine—ADRA2A—midbrain—multiple sclerosis	0.000839	0.00662	CbGeAlD
Phenoxybenzamine—ADRA2C—central nervous system—multiple sclerosis	0.000833	0.00656	CbGeAlD
Phenoxybenzamine—ADRA2A—spinal cord—multiple sclerosis	0.000819	0.00646	CbGeAlD
Phenoxybenzamine—ADRA2C—cerebellum—multiple sclerosis	0.000814	0.00642	CbGeAlD
Phenoxybenzamine—CALM2—brain—multiple sclerosis	0.00074	0.00583	CbGeAlD
Phenoxybenzamine—CALM1—brain—multiple sclerosis	0.000736	0.0058	CbGeAlD
Phenoxybenzamine—ADRA1A—brain—multiple sclerosis	0.000694	0.00547	CbGeAlD
Phenoxybenzamine—ADRA2A—nervous system—multiple sclerosis	0.00069	0.00544	CbGeAlD
Phenoxybenzamine—ADRA2A—central nervous system—multiple sclerosis	0.000664	0.00524	CbGeAlD
Phenoxybenzamine—ADRA2C—brain—multiple sclerosis	0.000661	0.00521	CbGeAlD
Phenoxybenzamine—ADRA2A—cerebellum—multiple sclerosis	0.000649	0.00512	CbGeAlD
Phenoxybenzamine—CYP3A4—nervous system—multiple sclerosis	0.000543	0.00428	CbGeAlD
Phenoxybenzamine—ADRA2A—brain—multiple sclerosis	0.000527	0.00416	CbGeAlD
Phenoxybenzamine—CYP3A4—central nervous system—multiple sclerosis	0.000523	0.00412	CbGeAlD
Phenoxybenzamine—CALM2—Disease—APOE—multiple sclerosis	1.9e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—APOE—multiple sclerosis	1.9e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CCL2—multiple sclerosis	1.89e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CCL2—multiple sclerosis	1.89e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	1.89e-05	8.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL10—multiple sclerosis	1.88e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL10—multiple sclerosis	1.88e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.87e-05	8.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD80—multiple sclerosis	1.86e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD80—multiple sclerosis	1.86e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.85e-05	7.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	1.85e-05	7.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.83e-05	7.86e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—POMC—multiple sclerosis	1.82e-05	7.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.82e-05	7.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.81e-05	7.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.8e-05	7.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.79e-05	7.7e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ALB—multiple sclerosis	1.78e-05	7.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.78e-05	7.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.78e-05	7.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—TYK2—multiple sclerosis	1.77e-05	7.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD80—multiple sclerosis	1.77e-05	7.61e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—MAPK1—multiple sclerosis	1.77e-05	7.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.77e-05	7.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.75e-05	7.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.74e-05	7.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.74e-05	7.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—TYK2—multiple sclerosis	1.72e-05	7.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—TYK2—multiple sclerosis	1.72e-05	7.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD80—multiple sclerosis	1.72e-05	7.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD80—multiple sclerosis	1.72e-05	7.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—MAPK1—multiple sclerosis	1.71e-05	7.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—MAPK1—multiple sclerosis	1.71e-05	7.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.7e-05	7.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CD86—multiple sclerosis	1.7e-05	7.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.7e-05	7.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.68e-05	7.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	1.68e-05	7.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL5—multiple sclerosis	1.68e-05	7.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.68e-05	7.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.67e-05	7.16e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ALB—multiple sclerosis	1.66e-05	7.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.65e-05	7.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.65e-05	7.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CD86—multiple sclerosis	1.65e-05	7.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CD86—multiple sclerosis	1.65e-05	7.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.65e-05	7.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—APOE—multiple sclerosis	1.64e-05	7.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.63e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—TYK2—multiple sclerosis	1.62e-05	6.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL5—multiple sclerosis	1.62e-05	6.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL5—multiple sclerosis	1.62e-05	6.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.62e-05	6.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	6.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.61e-05	6.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.59e-05	6.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—APOE—multiple sclerosis	1.59e-05	6.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—APOE—multiple sclerosis	1.59e-05	6.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—TYK2—multiple sclerosis	1.57e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—TYK2—multiple sclerosis	1.57e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.57e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.56e-05	6.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SPP1—multiple sclerosis	1.55e-05	6.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.55e-05	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.53e-05	6.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.52e-05	6.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNG—multiple sclerosis	1.52e-05	6.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.51e-05	6.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCR5—multiple sclerosis	1.51e-05	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	6.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SPP1—multiple sclerosis	1.5e-05	6.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SPP1—multiple sclerosis	1.5e-05	6.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.5e-05	6.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TYK2—multiple sclerosis	1.5e-05	6.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	1.49e-05	6.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	1.49e-05	6.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL2—multiple sclerosis	1.48e-05	6.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNG—multiple sclerosis	1.47e-05	6.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNG—multiple sclerosis	1.47e-05	6.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD4—multiple sclerosis	1.47e-05	6.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.46e-05	6.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCR5—multiple sclerosis	1.46e-05	6.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCR5—multiple sclerosis	1.46e-05	6.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TYK2—multiple sclerosis	1.45e-05	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TYK2—multiple sclerosis	1.45e-05	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	1.44e-05	6.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	1.44e-05	6.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL2—multiple sclerosis	1.43e-05	6.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL2—multiple sclerosis	1.43e-05	6.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD4—multiple sclerosis	1.42e-05	6.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD4—multiple sclerosis	1.42e-05	6.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.41e-05	6.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—POMC—multiple sclerosis	1.41e-05	6.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.41e-05	6.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.4e-05	5.99e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.39e-05	5.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.39e-05	5.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.39e-05	5.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—APOE—multiple sclerosis	1.37e-05	5.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—POMC—multiple sclerosis	1.36e-05	5.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—POMC—multiple sclerosis	1.36e-05	5.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.36e-05	5.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—multiple sclerosis	1.36e-05	5.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	5.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—multiple sclerosis	1.35e-05	5.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD4—multiple sclerosis	1.35e-05	5.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL2—multiple sclerosis	1.35e-05	5.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.33e-05	5.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—APOE—multiple sclerosis	1.33e-05	5.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—APOE—multiple sclerosis	1.33e-05	5.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.32e-05	5.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—multiple sclerosis	1.32e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—multiple sclerosis	1.32e-05	5.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—multiple sclerosis	1.31e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—multiple sclerosis	1.31e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD4—multiple sclerosis	1.31e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD4—multiple sclerosis	1.31e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL2—multiple sclerosis	1.3e-05	5.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL2—multiple sclerosis	1.3e-05	5.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	5.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—multiple sclerosis	1.29e-05	5.52e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.27e-05	5.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	5.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.26e-05	5.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.25e-05	5.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—multiple sclerosis	1.24e-05	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—multiple sclerosis	1.24e-05	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	1.24e-05	5.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CD80—multiple sclerosis	1.24e-05	5.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	5.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	1.24e-05	5.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.24e-05	5.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	5.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CD80—multiple sclerosis	1.2e-05	5.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.19e-05	5.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—POMC—multiple sclerosis	1.18e-05	5.07e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	1.18e-05	5.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.18e-05	5.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.17e-05	5.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.17e-05	5.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.16e-05	4.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	4.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.15e-05	4.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	4.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	4.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—POMC—multiple sclerosis	1.14e-05	4.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—STAT3—multiple sclerosis	1.14e-05	4.87e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.13e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	4.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	4.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.11e-05	4.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—STAT3—multiple sclerosis	1.1e-05	4.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—STAT3—multiple sclerosis	1.1e-05	4.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.1e-05	4.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.09e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.09e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.09e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.09e-05	4.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	4.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.06e-05	4.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TYK2—multiple sclerosis	1.05e-05	4.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—STAT3—multiple sclerosis	1.05e-05	4.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	1.05e-05	4.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MAPK1—multiple sclerosis	1.03e-05	4.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.03e-05	4.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	4.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TYK2—multiple sclerosis	1.01e-05	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TYK2—multiple sclerosis	1.01e-05	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—STAT3—multiple sclerosis	1.01e-05	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—STAT3—multiple sclerosis	1.01e-05	4.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MAPK1—multiple sclerosis	9.98e-06	4.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MAPK1—multiple sclerosis	9.98e-06	4.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	9.9e-06	4.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	9.85e-06	4.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	9.83e-06	4.22e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	9.75e-06	4.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—multiple sclerosis	9.74e-06	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	9.74e-06	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	9.73e-06	4.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—multiple sclerosis	9.72e-06	4.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	9.7e-06	4.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	9.64e-06	4.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	9.56e-06	4.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MAPK1—multiple sclerosis	9.53e-06	4.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	9.51e-06	4.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	9.51e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—multiple sclerosis	9.42e-06	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—multiple sclerosis	9.42e-06	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—multiple sclerosis	9.4e-06	4.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—multiple sclerosis	9.4e-06	4.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAPK1—multiple sclerosis	9.22e-06	3.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAPK1—multiple sclerosis	9.22e-06	3.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	9.2e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	9.18e-06	3.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	9.06e-06	3.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	9.05e-06	3.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	9.03e-06	3.88e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	9e-06	3.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	8.86e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—multiple sclerosis	8.72e-06	3.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—multiple sclerosis	8.68e-06	3.73e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	8.66e-06	3.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—multiple sclerosis	8.44e-06	3.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—multiple sclerosis	8.44e-06	3.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—multiple sclerosis	8.4e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—multiple sclerosis	8.4e-06	3.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—multiple sclerosis	8.25e-06	3.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	8.2e-06	3.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	8.04e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	8.04e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	8.03e-06	3.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—multiple sclerosis	7.99e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—multiple sclerosis	7.99e-06	3.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—multiple sclerosis	7.93e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	7.87e-06	3.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—multiple sclerosis	7.67e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—multiple sclerosis	7.67e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—APOE—multiple sclerosis	7.67e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	7.47e-06	3.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	7.46e-06	3.2e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	7.41e-06	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—multiple sclerosis	7.34e-06	3.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—multiple sclerosis	7.32e-06	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	7.31e-06	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	7.31e-06	3.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—multiple sclerosis	7.1e-06	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—multiple sclerosis	7.1e-06	3.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—multiple sclerosis	7.08e-06	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—multiple sclerosis	7.08e-06	3.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	6.92e-06	2.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—multiple sclerosis	6.82e-06	2.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	6.81e-06	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	6.8e-06	2.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	6.67e-06	2.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—multiple sclerosis	6.6e-06	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—multiple sclerosis	6.6e-06	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—POMC—multiple sclerosis	6.59e-06	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	6.58e-06	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	6.58e-06	2.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	6.45e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	6.45e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	6.05e-06	2.6e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—multiple sclerosis	6.01e-06	2.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	5.62e-06	2.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—multiple sclerosis	5.13e-06	2.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—multiple sclerosis	4.96e-06	2.13e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—multiple sclerosis	4.96e-06	2.13e-05	CbGpPWpGaD
